A.R. Sørensen

Monomeric insulins obtained by protein engineering and their medical implications

Jens Brange, Ulla Ribel, J. F. Hansen et al. · Nature · 1988 · 493 citations

Medicine, Biochemistry, Biotechnology +15

Soluble, prolonged-acting insulin derivatives. III. Degree of protraction, crystallizability and chemical stability of insulins substituted in positions A21, B13, B23, B27 and B30

Jan Markussen, I. Diers, Philip Hougaard et al. · Protein Engineering Design and Selection · 1988 · 96 citations

Pharmacy, Biochemistry, Pharmacology +14

Intranasal Administration of Insulin With Phospholipid as Absorption Enhancer: Pharmacokinetics in Normal Subjects

Kirsten Drejer, Allan Vaag, K. Bech et al. · Diabetic Medicine · 1992 · 80 citations

Pharmacy, Pharmacokinetics, Pharmacology +15

In Vitro and In Vivo Potency of Insulin Analogues Designed for Clinical Use

Aa. Vølund, Jens Brange, Kirsten Drejer et al. · Diabetic Medicine · 1991 · 75 citations

Medicine, Medicinal Chemistry, Pharmacology +16

Soluble, prolonged-acting insulin derivatives. II. Degree of protraction and crystallizability of insulins substituted in positions A17, B8, B13, B27 and B30

Jan Markussen, I. Diers, Anne Engesgaard et al. · Protein Engineering Design and Selection · 1987 · 69 citations

Pharmacy, Biochemistry, Bioavailability +8